Cambridge Investment Research Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.45M | Buy |
|
|||||
|
2025
Q2 | $451K | Buy |
|
|||||
|
2025
Q1 | $213K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $202K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $536K | Buy |
|
|||||
|
2021
Q4 | $556K | Sell |
|
|||||
|
2021
Q3 | $629K | Sell |
|
|||||
|
2021
Q2 | $770K | Buy |
|
|||||
|
2021
Q1 | $628K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $210K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $220K | Buy |
|